Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug…
| Price | $180.16 |
|---|---|
| Market cap | $49.64B |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| Exchange | NYSE |
| 52-week range | 127.58648-193.07 |
| Dividend (TTM) | $3.98 per share |
| Beta | 0.26 |
Explore BDX's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.